Sodium azide removal

Sodium azide is a chemical preservative commonly used in antibody solutions, but its cytotoxicity and interference with conjugation reactions necessitate its removal for sensitive applications. Sodium azide is a chemical found in various products and applications, including automobile airbags, where it acts as a propellant, and pest control, where it is used for its effectiveness against rodents and insects. This azide removal protocol outlines two effective methods—dialysis and desalting—tailored to different sample volumes and experimental needs. Dialysis is ideal for larger volumes, while desalting suits smaller preparations. Both techniques ensure antibodies are safe for cell culture and conjugation workflows.

Introduction

Sodium azide is widely used to prevent microbial contamination in antibody formulations. However, its presence poses challenges in downstream applications such as cell culture and enzyme-linked assays. Toxic to living cells and inhibitory to enzymes like horseradish peroxidase, sodium azide must be removed prior to use in sensitive biological systems. There is no specific antidote for sodium azide poisoning, making prevention and thorough removal especially critical. Sodium azide can affect the heart, brain, and other organs by interfering with oxygen use, and inhalation of sodium azide gas causes the most harm compared to ingestion or skin contact, particularly in enclosed spaces. Thisprotocol provides a reliable guide for removing sodium azide from antibody solutions, ensuring compatibility with a broad range of experimental setups. Whether preparing antibodies for conjugation or cell-based assays, this protocol supports researchers in achieving optimal performance and reproducibility.

Background and principles

The protocol leverages two core biochemical principles: molecular weight-based separation and size exclusion. Dialysis uses a semi-permeable membrane with a pore size cut-off (10–30 kDa) that retains antibodies (eg, IgG at 150 kDa) while allowing sodium azide (65 Da) to diffuse out. Desalting, on the other hand, employs resins like Sephadex G25 to separate molecules based on size. In typical desalting procedures for protein purification, desalting columns are commonly used. These columns utilize size exclusion chromatography for group separation of molecules, where larger antibody molecules elute first and smaller contaminants like sodium azide are retained longer. Each desalting column has a defined fractionation range and exclusion limit, which determine the molecular weight window for effective separation of high molecular weight proteins from low molecular weight substances. These methods preserve antibody structure and function while effectively removing low-molecular-weight preservatives, making them suitable for high-sensitivity applications.

Assemble the dialysis unit, as recommended by the manufacturer. Pre-condition the unit for a minimum of 1–2 min in the dialysis buffer to allow the membrane to hydrate.

timelineNumber

1

Stage 1 - Dialysis

A dialysis unit can be used to remove sodium azide from samples of 0.1 mL to 70 mL in volume. This is a semi-permeable membrane available in a wide range of size dimensions and pore sizes. Using a membrane with a pore size cut-off at 10-30 kDa will allow the azide to pass through the membrane but will retain the antibody and other proteins in the solution.

The molecular weight of IgG is 150 kDa (IgM is ~600 kDa). The molecular weight of sodium azide is 65 Da.

​A dialysis unit can be used to remove sodium azide from samples of 0.1 mL to 70 mL in volume. This is a semi-permeable membrane available in a wide range of size dimensions and pore sizes. Using a membrane with a pore size cut-off at 10-30 kDa will allow the azide to pass through the membrane but will retain the antibody and other proteins in the solution.

Assemble the dialysis unit, as recommended by the manufacturer. Pre-condition the unit for a minimum of 1–2 min in the dialysis buffer to allow the membrane to hydrate.

Transfer the antibody solution into the dialysis unit.

Place the dialysis unit into a suitably sized beaker containing at least 1 L of buffer against which the antibody is to be dialyzed. Place the beaker on a magnetic stirrer and dialyze for a minimum of 1 h at 4°C.

Change the buffer and dialyze again for at least 1 h. Repeat until the desired number of buffer changes has been achieved. Ensure that the buffer is changed at least 3 times.

Stage 2 - Desalting

This procedure is suitable for smaller volume of 1–3 mL. Desalting resins have size exclusion properties and consist of small particles with a range of pore sizes.

Size exclusion is a method used to separate molecules in solution by their molecules in solution by their molecular weight. Particles of varying molecular weight will elute through a size exclusion matrix at different rates. For example, large molecules cannot enter the pores of the matrix and therefore are eluted first, whereas smaller molecules will penetrate the pores within the beads and elute later.

A Sephadex G25 column system or equivalent will effectively remove sodium azide from an antibody sample. Pre-packed Sephadex spin columns are readily available and can be used for this procedure.

Materials required

• Sephadex G25 spin column
• Equilibration buffer
• Centrifuge

Remove the cap from the spin column and centrifuge at 1,000 x g for 2 min to remove the storage solution.

Put the column in a collecting tube.

Fill the column with equilibration buffer as advised by the manufacturer and centrifuge at 1,000 x g for 2 min.

Repeat 3 times and discard the collected flow-through.

Add 1–3 mL of antibody sample slowly to the middle of the packed bed and centrifuge at 1,000 x g for 2 min.

Collect and recover the eluate (antibody) located in the collection tube.

Health effects

Sodium azide is a potentially deadly chemical that poses significant health risks if not handled with care. Exposure to sodium azide can occur through inhalation, ingestion, or direct skin contact, each route carrying serious consequences. When sodium azide comes into contact with acids or water, it can release hydrazoic acid, a highly toxic gas. Inhalation of this toxic gas can lead to symptoms such as restlessness, weakness, and skin burns, and in severe cases, can be fatal. Sodium azide prevents cells from utilizing oxygen, which can result in rapid cell death and is especially harmful to vital organs like the heart and brain. Prolonged or high-level exposure may cause irreversible brain damage and other long-term health effects. Because of these dangers, it is crucial to understand and respect the health effects associated with sodium azide in any laboratory setting.

Comparison to other methods

Compared to chemical precipitation or ultrafiltration, dialysis and desalting offer gentler, more selective purification, with several advantages such as higher protein recovery, minimal denaturation, and compatibility with sensitive samples. Dialysis is preferred for larger volumes and provides thorough removal over multiple buffer exchanges. Desalting is faster and ideal for small-scale preparations, using pre-packed spin columns for convenience. Unlike chemical treatments, these methods avoid harsh conditions that could denature antibodies and can also help remove contaminants such as human serum albumin from samples. When selecting a purification protocol, it is important to use the same type of method that matches the antibody class to ensure optimal binding and separation. While ultrafiltration can also remove small molecules, it may concentrate proteins unevenly or require specialized equipment. Abcam’s protocol balances efficiency, accessibility, and protein integrity, making it a practical choice for most lab environments.

Applications

This protocol is essential for preparing antibodies for cell culture, immunocytochemistry, flow cytometry, and conjugation reactions. Sodium azide-free antibodies are critical in live-cell assays where cytotoxicity must be avoided. The removal process also ensures compatibility with enzyme-linked detection systems, preventing inhibition of HRP or alkaline phosphatase. Researchers working with recombinant antibodies, therapeutic candidates, or diagnostic reagents benefit from azide-free preparations. Abcam’s carrier-free antibody range further supports these applications by offering ready-to-use solutions free from sodium azide, BSA, and glycerol, streamlining experimental workflows.

In case of accidental exposure to sodium azide, immediately move to an area with fresh air to reduce health risks. Any contaminated clothing or materials should be placed in a plastic bag or plastic bags for safe disposal to prevent environmental contamination.

Limitations

While effective, the protocol has limitations based on sample volume and equipment availability. Dialysis requires time and access to magnetic stirrers and cold storage, making it less suitable for rapid processing. Desalting is limited to small volumes (1–3 mL) and may not achieve complete removal in a single pass. Additionally, both methods depend on proper buffer selection and membrane or resin quality. Incomplete equilibration or insufficient buffer changes can lead to residual azide. Users must also ensure antibody stability during purification, as repeated handling may affect sensitive proteins.

Troubleshooting

Common issues include incomplete azide removal, low antibody recovery, and sample dilution. To improve removal efficiency, ensure at least three buffer changes during dialysis and use fresh, properly equilibrated buffers. For desalting, verify column integrity and centrifuge settings to avoid sample loss. If antibody concentration drops, consider post-purification concentration methods. Cloudiness or precipitation may indicate protein instability—adjust buffer composition or temperature accordingly. Always follow manufacturer guidelines for dialysis units and spin columns. If persistent problems occur, Abcam’s carrier-free antibody products offer a reliable alternative without purification steps.

Safety precautions and disposal

Working with sodium azide in protein samples requires strict adherence to safety protocols to protect both personnel and the environment. Always wear appropriate protective clothing, including gloves and a face mask, and ensure that work is conducted in a well-ventilated area or fume hood to minimize exposure to toxic gases. In the event of accidental exposure, seek medical attention immediately, as sodium azide can cause severe health effects even at low concentrations.

Proper disposal of sodium azide is essential. Never pour sodium azide or solutions containing it down the drain, as it can react with metals in plumbing to form explosive compounds and contaminate water sources. Instead, use a semi-permeable membrane, such as a dialysis membrane, to remove sodium azide from protein samples during buffer exchange. For smaller sample volumes, a desalting column or spin column with an appropriate equilibration buffer can effectively remove low molecular weight contaminants, including sodium azide. All waste containing sodium azide should be collected and disposed of through a licensed hazardous waste disposal company, following the manufacturer’s instructions and institutional guidelines. By following these methods and safety precautions, you can ensure the safe handling and disposal of sodium azide in the laboratory.